These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 36986595)

  • 1. Updates on Biodegradable Formulations for Ocular Drug Delivery.
    Tsung TH; Chen YH; Lu DW
    Pharmaceutics; 2023 Feb; 15(3):. PubMed ID: 36986595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of Recent Advances in Nano-Based Ocular Drug Delivery.
    Liu LC; Chen YH; Lu DW
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Nanomicellar Formulation Approaches for Anterior and Posterior Segment Ocular Drug Delivery.
    Cholkar K; Patel A; Vadlapudi AD; Mitra AK
    Recent Pat Nanomed; 2012; 2(2):82-95. PubMed ID: 25400717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application.
    Tsai CH; Wang PY; Lin IC; Huang H; Liu GS; Tseng CL
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30235809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomaterial Drug Delivery Systems for Prominent Ocular Diseases.
    Sapowadia A; Ghanbariamin D; Zhou L; Zhou Q; Schmidt T; Tamayol A; Chen Y
    Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Niosomal Drug Delivery Systems for Ocular Disease-Recent Advances and Future Prospects.
    Durak S; Esmaeili Rad M; Alp Yetisgin A; Eda Sutova H; Kutlu O; Cetinel S; Zarrabi A
    Nanomaterials (Basel); 2020 Jun; 10(6):. PubMed ID: 32570885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocarriers Based Ocular Therapeutics: Updates, Challenges and Future Prospectives.
    Kaushal U; Kaur M; Nagpal M; Bhuyan M; Gounder KP
    Curr Drug Res Rev; 2023; 15(1):15-28. PubMed ID: 36100986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming Treatment Challenges in Posterior Segment Diseases with Biodegradable Nano-Based Drug Delivery Systems.
    Wu KY; Joly-Chevrier M; Akbar D; Tran SD
    Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid Nanoparticles as a Promising Drug Delivery Carrier for Topical Ocular Therapy-An Overview on Recent Advances.
    Jacob S; Nair AB; Shah J; Gupta S; Boddu SHS; Sreeharsha N; Joseph A; Shinu P; Morsy MA
    Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable Polymer-Based Drug-Delivery Systems for Ocular Diseases.
    Tsung TH; Tsai YC; Lee HP; Chen YH; Lu DW
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural biodegradable polymers based nano-formulations for drug delivery: A review.
    George A; Shah PA; Shrivastav PS
    Int J Pharm; 2019 Apr; 561():244-264. PubMed ID: 30851391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical application of polymeric nanomicelles in ophthalmology: a review on research efforts for the noninvasive delivery of ocular therapeutics.
    Grimaudo MA; Pescina S; Padula C; Santi P; Concheiro A; Alvarez-Lorenzo C; Nicoli S
    Expert Opin Drug Deliv; 2019 Apr; 16(4):397-413. PubMed ID: 30889977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten Years of Knowledge of Nano-Carrier Based Drug Delivery Systems in Ophthalmology: Current Evidence, Challenges, and Future Prospective.
    Zhang J; Jiao J; Niu M; Gao X; Zhang G; Yu H; Yang X; Liu L
    Int J Nanomedicine; 2021; 16():6497-6530. PubMed ID: 34588777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naringenin Nano-Delivery Systems and Their Therapeutic Applications.
    Bhia M; Motallebi M; Abadi B; Zarepour A; Pereira-Silva M; Saremnejad F; Santos AC; Zarrabi A; Melero A; Jafari SM; Shakibaei M
    Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33672366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in ocular drug delivery.
    Achouri D; Alhanout K; Piccerelle P; Andrieu V
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular drug delivery systems: An overview.
    Patel A; Cholkar K; Agrahari V; Mitra AK
    World J Pharmacol; 2013; 2(2):47-64. PubMed ID: 25590022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomes as vehicles for topical ophthalmic drug delivery and ocular surface protection.
    López-Cano JJ; González-Cela-Casamayor MA; Andrés-Guerrero V; Herrero-Vanrell R; Molina-Martínez IT
    Expert Opin Drug Deliv; 2021 Jul; 18(7):819-847. PubMed ID: 33412914
    [No Abstract]   [Full Text] [Related]  

  • 18. Advances in Biodegradable Nano-Sized Polymer-Based Ocular Drug Delivery.
    Lynch C; Kondiah PPD; Choonara YE; du Toit LC; Ally N; Pillay V
    Polymers (Basel); 2019 Aug; 11(8):. PubMed ID: 31434273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodegradable Nanoparticle for Cornea Drug Delivery: Focus Review.
    Mobaraki M; Soltani M; Zare Harofte S; L Zoudani E; Daliri R; Aghamirsalim M; Raahemifar K
    Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33353013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrogel-based ocular drug delivery systems for hydrophobic drugs.
    Torres-Luna C; Fan X; Domszy R; Hu N; Wang NS; Yang A
    Eur J Pharm Sci; 2020 Nov; 154():105503. PubMed ID: 32745587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.